CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 108 filers reported holding CYTOKINETICS INC in Q1 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,632,000 | +31.8% | 134,303 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $1,238,000 | +0.8% | 134,826 | +4.2% | 0.00% | 0.0% |
| Q2 2016 | $1,228,000 | +36.1% | 129,386 | +1.1% | 0.00% | +100.0% |
| Q1 2016 | $902,000 | -32.1% | 127,988 | +0.7% | 0.00% | -50.0% |
| Q4 2015 | $1,329,000 | +57.8% | 127,055 | +0.9% | 0.00% | +100.0% |
| Q3 2015 | $842,000 | -3.2% | 125,895 | -2.8% | 0.00% | 0.0% |
| Q2 2015 | $870,000 | +12.1% | 129,536 | +13.2% | 0.00% | 0.0% |
| Q1 2015 | $776,000 | -15.9% | 114,474 | -0.6% | 0.00% | 0.0% |
| Q4 2014 | $923,000 | +124.0% | 115,217 | -1.6% | 0.00% | 0.0% |
| Q3 2014 | $412,000 | -24.0% | 117,069 | +3.2% | 0.00% | 0.0% |
| Q2 2014 | $542,000 | -38.9% | 113,429 | +21.4% | 0.00% | 0.0% |
| Q1 2014 | $887,000 | +77.8% | 93,408 | +21.7% | 0.00% | 0.0% |
| Q4 2013 | $499,000 | -15.4% | 76,766 | -1.5% | 0.00% | 0.0% |
| Q3 2013 | $590,000 | – | 77,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,723,170 | $13,940,000 | 5.01% |
| RP Management, LLC | 875,656 | $7,084,000 | 3.54% |
| BVF INC/IL | 3,801,817 | $30,757,000 | 3.44% |
| DAFNA Capital Management LLC | 400,294 | $3,238,000 | 1.40% |
| Virtus ETF Advisers LLC | 33,758 | $273,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 67,352 | $545,000 | 0.44% |
| WASATCH ADVISORS LP | 3,188,487 | $25,795,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 1,459,706 | $11,809,000 | 0.26% |
| Campbell & CO Investment Adviser LLC | 43,844 | $355,000 | 0.18% |
| Fosun International Ltd | 239,792 | $1,981,000 | 0.13% |